Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden.

Syrimi, E; Gunasekera, S; Norton, A; Velangi, M; Motwani, J; Hiwarkar, P; (2017) Single dose Rasburicase is a clinically effective pharmacoeconomic approach for preventing tumour lysis syndrome in children with high tumour burden. Br J Haematol 10.1111/bjh.14689 .

http://ift.tt/2rFkW1q